168 related articles for article (PubMed ID: 38095707)
1. Comparison of the efficacy and adverse effects of unilateral or bilateral botulinum toxin injections for adductor spasmodic dysphonia: a systematic review and meta-analysis.
Liu Y; Chen F; Liang F; Wang C; Chen D; Zhou J; Zhang L; Xiao X; He R; Tang L; Tian L; Zhou L
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1357-1369. PubMed ID: 38095707
[TBL] [Abstract][Full Text] [Related]
2. Alternating Unilateral Versus Bilateral Injections of Botulinum Toxin for the Treatment of Adductor Spasmodic Dysphonia.
Lee SJ; Kang MS; Choi HS; Lim JY
Otolaryngol Head Neck Surg; 2021 Apr; 164(4):815-820. PubMed ID: 32957836
[TBL] [Abstract][Full Text] [Related]
3. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
van Esch BF; Wegner I; Stegeman I; Grolman W
Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
5. Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort.
French G; Bosch JD; Randall DR
J Otolaryngol Head Neck Surg; 2020 Jan; 49(1):4. PubMed ID: 31937363
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Onabotulinum Toxin A Treatment for Adductor Spasmodic Dysphonia and Laryngeal Tremor.
Patel PN; Kabagambe EK; Starkweather JC; Keller M; Gamsarian V; Lee J; Kulkarni V; Garrett CG; Francis DO
JAMA Otolaryngol Head Neck Surg; 2018 Apr; 144(4):293-299. PubMed ID: 29423509
[TBL] [Abstract][Full Text] [Related]
7. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study.
Cha W; Jang JY; Wang SG; Kang JH; Jo MG
J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509
[TBL] [Abstract][Full Text] [Related]
8. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia in a large cohort.
Dharia I; Bielamowicz S
Laryngoscope; 2020 Nov; 130(11):2659-2662. PubMed ID: 31837152
[TBL] [Abstract][Full Text] [Related]
9. Quality of Life After Botulinum Toxin Injection in Patients With Adductor Spasmodic Dysphonia; a Systematic Review and Meta-analysis.
Faham M; Ahmadi A; Silverman E; Harouni GG; Dabirmoghaddam P
J Voice; 2021 Mar; 35(2):271-283. PubMed ID: 31477348
[TBL] [Abstract][Full Text] [Related]
10. Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study.
Kim JW; Park JH; Park KN; Lee SW
ScientificWorldJournal; 2014; 2014():327928. PubMed ID: 25383369
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated with Failure of Botulinum Toxin Injection in Adductor Spasmodic Dysphonia.
Zhao K; Guillaud M; Hu A
Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):996-1002. PubMed ID: 32468829
[TBL] [Abstract][Full Text] [Related]
12. Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective.
Schuering JHC; Heijnen BJ; Sjögren EV; Langeveld APM
Laryngoscope; 2020 Mar; 130(3):741-746. PubMed ID: 31169922
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
Maloney AP; Morrison MD
J Otolaryngol; 1994 Jun; 23(3):160-4. PubMed ID: 8064952
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes.
Novakovic D; Waters HH; D'Elia JB; Blitzer A
Laryngoscope; 2011 Mar; 121(3):606-12. PubMed ID: 21298641
[TBL] [Abstract][Full Text] [Related]
15. Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor.
Orbelo DM; Duffy JR; Hughes Borst BJ; Ekbom D; Maragos NE
J Voice; 2014 Jan; 28(1):123-7. PubMed ID: 24080335
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing long-term treatment response to botulinum toxin injection for spasmodic dysphonia.
Kang MS; Lee SJ; Choi HS; Lim JY
Clin Otolaryngol; 2021 Mar; 46(2):436-444. PubMed ID: 33260261
[TBL] [Abstract][Full Text] [Related]
17. [Treatment efficacy of electronic endoscope-guided botulinum toxin injection in adductor spasmodic dysphonia patients].
Ren J; Yang H; Wang H; Zou J; Lv D; Yu L; Zheng Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Nov; 34(11):1019-1023. PubMed ID: 33254323
[No Abstract] [Full Text] [Related]
18. Alternating unilateral botulinum toxin type A (BOTOX) injections for spasmodic dysphonia.
Koriwchak MJ; Netterville JL; Snowden T; Courey M; Ossoff RH
Laryngoscope; 1996 Dec; 106(12 Pt 1):1476-81. PubMed ID: 8948606
[TBL] [Abstract][Full Text] [Related]
19. Botulinum Toxin Dosing Trends in Spasmodic Dysphonia Over a 20-year Period.
Namin AW; Christopher KM; Eisenbeis JF
J Voice; 2017 Jan; 31(1):107-110. PubMed ID: 27005439
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Botulinum Toxin Injections and Type 2 Thyroplasty for Adductor Spasmodic Dysphonia.
Sanuki T; Takemoto N
Laryngoscope; 2023 Dec; 133(12):3443-3448. PubMed ID: 37278482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
